Your Article Summary
Early Prediction of Response to First-Line Therapy Using Integrated 18F-FDG PET/CT for Patients with Advanced/Metastatic Non-small Cell Lung Cancer
Journal of Thoracic Oncology, 06/29/09
Lee DH et al. - Single 18-fluorodeoxyglucose positron emission tomography/computed tomography scan taken after one cycle of treatment could predict progressive disease earlier than standard radiographic evaluation and can be used as a measure to avoid ineffective systemic chemotherapy.
Related Articles
Lung cancer: a biologically different disease in women?
Women's Health, 10/30/09
Relevance Score: 73%
Oestrogen plus progestin and lung cancer in postmenopausal women (Womens Health Initiative trial): a post-hoc analysis of a randomised controlled trial
The Lancet, 10/12/09
Relevance Score: 72%
Haplotype and Cell Proliferation Analyses of Candidate Lung Cancer Susceptibility Genes on Chromosome 15q24-25.1
Cancer Research, 10/06/09
Relevance Score: 71%
Noninvasive detection of lung cancer by analysis of exhaled breath
BMC Cancer, 10/09/09
Relevance Score: 70%
African American lung cancer patients may have different response to new cancer-fighting drugs
EurekAlert, 10/08/09
Relevance Score: 70%
Today in Diagnostic/Lung Function...keeping you current
Receive free subspecialty "5-minute updates" via email
Comparison of Ultrasound and CT in the Evaluation of Pneumonia Complicated by Parapneumonic Effusion in Children
American Journal of Roentgenology, 12/02/09
Comparative analysis of selected exhaled breath biomarkers obtained with two different temperature-controlled devices
BMC Pulmonary Medicine, 12/02/09
Evaluation of the nitrate reductase assay for rapid detection of extensively drug-resistant tuberculosis
The International Journal of Tuberculosis and Lung Disease, 12/01/09
Today in Lung/Thoracic Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
The Role of EGFR Inhibition in the Treatment of Non-Small Cell Lung Cancer
The Oncologist, 12/02/09
Prognostic Factors for Resected Non-Small Cell Lung Cancer with pN2 Status: Implications for Use of Postoperative Radiotherapy
The Oncologist, 12/02/09
Associations of MDM2 SNP309, Transcriptional Activity, mRNA Expression, and Survival in Stage I Non-Small-Cell Lung Cancer Patients with Wild-Type p53 Tumors
Annals of Surgical Oncology, 12/02/09

See Latest Articles